Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study

References

• Wallenius M, Salvesen KA, Daltveit AK, Skomsvoll JF. Reproductive trends in females with inflammatory joint disease. BMC Pregnancy Childb. 2016;16(1):123.
   PubMedGoogle Scholar
• Wallenius M, Salvesen KA, Daltveit AK, Skomsvoll JF. Secular trends of pregnancies in women with inflammatory connective tissue disease. Acta Obstet Gynecol Scand. 2015;94(11):1195–202.
   PubMed Web of Science ®Google Scholar
• Zbinden A, van den Brandt S, Ostensen M, Villiger PM, Forger F. Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters. Rheumatology (Oxford). 2018;57(7):1235.
   PubMed Web of Science ®Google Scholar
• Moroni G, Doria A, Giglio E, Tani C, Zen M, Strigini F, et al. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. J Autoimmun. 2016;74:6–12.
   PubMed Web of Science ®Google Scholar
• Moroni G, Doria A, Giglio E, Imbasciati E, Tani C, Zen M, et al. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. J Autoimmun. 2016;74:194–200.
   PubMed Web of Science ®Google Scholar
• Bortoli A, Pedersen N, Duricova D, D′Inca R, Gionchetti P, Panelli MR, et al. Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003–2006. Aliment Pharmacol Ther. 2011;34(7):724–34.
   PubMed Web of Science ®Google Scholar
• Broms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H. Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure. Inflamm Bowel Dis. 2014;20:1091–8.
   PubMed Web of Science ®Google Scholar
• van der Woude CJ, Ardizzone S, Bengtson MB, Fiorino G, Fraser G, Katsanos K, et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis. 2015;9(2):107–24.
   PubMed Web of Science ®Google Scholar
• Gotestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795–810.
   PubMed Web of Science ®Google Scholar
• Teng YKO, Bredewold EOW, Rabelink TJ, Huizinga TWJ, Eikenboom HCJ, Limper M, et al. An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus. Rheumatology (Oxford). 2017;57(10):1707–20.
   Web of Science ®Google Scholar
• Nahal SK, Selmi C, Gershwin ME. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus. J Autoimmun. 2018;93:16–23.
   PubMed Web of Science ®Google Scholar
• Ostensen M. Contraception and pregnancy counselling in rheumatoid arthritis. Curr Opin Rheumatol. 2014;26:302–7.
   PubMed Web of Science ®Google Scholar
• Gawron LM, Sanders J, Steele KP, Flynn AD. Reproductive planning and contraception for women with inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22(2):459–64.
   PubMed Web of Science ®Google Scholar
• Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76(3):476–85.
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare. Vital statistics of Japan 2015 (in Japanese). [Online]. Available from: https://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei15/index.html [last received 19 Nov 2018]
   Google Scholar
• Takeda S, Kanayama N, Itakura A, Ito H, Umino S, Kikuchi A, et al. Annual report of the Perinatology Committee, Japan Society of Obstetrics and Gynecology, 2015 (in Japanese). Acta Obst Gynaec Jpn 2017;69:1445–79.
   Google Scholar
• Kanayama N, Ikeda T, Itakura A, Ito H, Umino S, Sameshima H, et al. Annual report of the Perinatology Committee, Japan Society of Obstetrics and Gynecology, 2016 (in Japanese). Acta Obst Gynaec Jpn. 2018;70:1504–37.
   Google Scholar
• Saito H, Jwa SC, Kuwahara A, Saito K, Ishikawa T, Ishihara O, et al. Assisted reproductive technology in Japan: a summary report for 2015 by The Ethics Committee of The Japan Society of Obstetrics and Gynecology. Reprod Med Biol. 2018;17(1):20–8.
   PubMed Web of Science ®Google Scholar
• Bharti B, Lee SJ, Lindsay SP, Wingard DL, Jones KL, Lemus H, et al. Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the organization of teratology information specialists autoimmune diseases in pregnancy project. J Rheumatol. 2015;42(8):1376–82.
   PubMed Web of Science ®Google Scholar
• Ostensen M. Rheumatoid arthritis: the effect of RA and medication on female fertility. Nat Rev Rheumatol. 2014;10(9):518–9.
   PubMed Web of Science ®Google Scholar
• Brouwer J, Hazes JM, Laven JS, Dolhain RJ. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis. 2015;74(10):1836–41.
   PubMed Web of Science ®Google Scholar
• Gotestam Skorpen C, Lydersen S, Gilboe IM, Skomsvoll JF, Salvesen KA, Palm O, et al. Women with systemic lupus erythematosus get pregnant more easily than women with rheumatoid arthritis. Rheumatology (Oxford). 2018;57:1072–9.
   PubMed Web of Science ®Google Scholar
• Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant. 2008;24(2):519–25.
   PubMed Web of Science ®Google Scholar
• Carvalheiras G, Vita P, Marta S, Trovao R, Farinha F, Braga J, et al. Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clinic Rev Allerg Immunol. 2010;38(2-3):302–6.
   PubMed Web of Science ®Google Scholar
• Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford). 2002;41(6):643–50.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Tandon A, Ibanez D, Urowitz MB. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol. 2010;37(4):754–8.
   PubMed Web of Science ®Google Scholar
• Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 1991;34(12):1538–45.
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J, Hughes GR, et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol. 1996;35(2):133–8.
   PubMedGoogle Scholar
• Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199(2):127.e1–6.
   PubMed Web of Science ®Google Scholar
• Bundhun PK, Soogund MZ, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001-2016. J Autoimmun. 2017;79:17–27.
   PubMed Web of Science ®Google Scholar
• Bramham K, Hunt BJ, Bewley S, Germain S, Calatayud I, Khamashta MA, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol. 2011;38(9):1906–13.
   PubMed Web of Science ®Google Scholar
• Tedeschi SK, Guan H, Fine A, Costenbader KH, Bermas B. Organ-specific systemic lupus erythematosus activity during pregnancy is associated with adverse pregnancy outcomes. Clin Rheumatol. 2016;35(7):1725–32.
   PubMed Web of Science ®Google Scholar
• Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin North Am. 2007;33(2):237–52.
   PubMed Web of Science ®Google Scholar
• Bleau N, Patenaude V, Abenhaim HA. Risk of venous thromboembolic events in pregnant patients with autoimmune diseases: a population-based study. Clin Appl Thromb Hemost. 2016;22(3):285–91.
   PubMed Web of Science ®Google Scholar
• Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52(2):514–21.
   PubMed Web of Science ®Google Scholar
• Ostensen M, Husby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum. 1983;26(9):1155.
   PubMed Web of Science ®Google Scholar
• de Man YA, Dolhain RJ, van de Geijn FE, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59(9):1241–8.
   PubMed Web of Science ®Google Scholar
• de Man YA, Hazes JM, van der Heide H, Willemsen SP, de Groot CJ, Steegers EA, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum. 2009;60(11):3196–206.
   PubMed Web of Science ®Google Scholar
• Weix J, Haupl T, Raio L, Villiger PM, Forger F. The physiologic increase in expression of some type I IFN-inducible genes during pregnancy is not associated with improved disease activity in pregnant patients with rheumatoid arthritis. Transl Res. 2013;161(6):505–12.
   PubMed Web of Science ®Google Scholar
• Ince-Askan H, Hazes JMW, Dolhain R. Identifying clinical factors associated with low disease activity and remission of rheumatoid arthritis during pregnancy. Arthritis Care Res (Hoboken). 2017;69(9):1297–303.
   PubMed Web of Science ®Google Scholar
• van den Brandt S, Zbinden A, Baeten D, Villiger PM, Ostensen M, Forger F. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther. 2017;19(1):64.
   PubMedGoogle Scholar
• Persellin RH. The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis 1976;27(9):922–7.
   PubMedGoogle Scholar
• Jethwa H, Lam S, Smith C, Giles I. Does rheumatoid arthritis really improve during pregnancy? A systematic review and metaanalysis. J Rheumatol. 2019;46(3):245–250.
   PubMed Web of Science ®Google Scholar
• Forger F, Marcoli N, Gadola S, Moller B, Villiger PM, Ostensen M. Pregnancy induces numerical and functional changes of CD4 + CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67(7):984–90.
   PubMed Web of Science ®Google Scholar
• Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med. 2004;200(3):277–85.
   PubMed Web of Science ®Google Scholar
• de Lima-Karagiannis A, Zelinkova-Detkova Z, van der Woude CJ. The effects of active IBD during pregnancy in the era of novel IBD therapies. Am J Gastroenterol. 2016;111(9):1305–12.
   PubMed Web of Science ®Google Scholar
• Bengtson MB, Martin CF, Aamodt G, Vatn MH, Mahadevan U. Inadequate gestational weight gain predicts adverse pregnancy outcomes in mothers with inflammatory bowel disease: results from a Prospective US Pregnancy Cohort. Dig Dis Sci. 2017;62(8):2063–9.
   PubMed Web of Science ®Google Scholar
• Pedersen N, Bortoli A, Duricova D, D′Inca R, Panelli MR, Gisbert JP, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther. 2013;38(5):501–12.
   PubMed Web of Science ®Google Scholar
• Getahun D, Fassett MJ, Longstreth GF, Koebnick C, Langer-Gould AM, Strickland D, et al. Association between maternal inflammatory bowel disease and adverse perinatal outcomes. J Perinatol. 2014;34(6):435–40.
   PubMed Web of Science ®Google Scholar
• Cornish JA, Tan E, Teare J, Teoh TG, Rai R, Darzi AW, et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum. 2007;50(8):1128–38.
   PubMed Web of Science ®Google Scholar
• Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, et al. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group. Gastroenterology. 2019;156(5):1508–24.
   PubMed Web of Science ®Google Scholar
• Komaki F, Komaki Y, Micic D, Ido A, Sakuraba A. Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-alpha use in females with immune mediated diseases; a systematic review and meta-analysis. J Autoimmun. 2017;76:38–52.
   PubMed Web of Science ®Google Scholar
• Desai RJ, Bateman BT, Huybrechts KF, Patorno E, Hernandez-Diaz S, Park Y, et al. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ. 2017;356:j895.
   PubMed Web of Science ®Google Scholar
• Shihab Z, Yeomans ND, De Cruz P. Anti-tumour necrosis factor alpha therapies and inflammatory bowel disease pregnancy outcomes: a meta-analysis. Eccojc. 2016;10(8):979–88.
   Google Scholar
• Diav-Citrin O, Otcheretianski-Volodarsky A, Shechtman S, Ornoy A. Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. Reprod Toxicol. 2014;43:78–84.
   PubMed Web of Science ®Google Scholar
• Broms G, Granath F, Ekbom A, Hellgren K, Pedersen L, Sorensen HT, et al. Low risk of birth defects for infants whose mothers are treated with anti-tumor necrosis factor agents during pregnancy. Clin Gastroenterol Hepatol. 2016;14:234–41.e1-5.
   PubMed Web of Science ®Google Scholar
• Julsgaard M, Christensen LA, Gibson PR, Gearry RB, Fallingborg J, Hvas CL, et al. Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology. 2016;151(1):110–9.
   PubMed Web of Science ®Google Scholar